Immunoglobulin and lymphocyte decrease concurrent with adverse reactions induced by methotrexate for RA [6]

Annals of the Rheumatic Diseases

Volumn 59, Issue 6, 2000, Pages 495-496

  Inokuma, Shigeko ^a   Kono, Hajime ^a   Nakayama, Hisanori ^a   Yamazaki, Junko ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; METHOTREXATE;

ADULT; FEMALE; GRANULOCYTOPENIA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STEROID THERAPY;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; MALE; METHOTREXATE; MIDDLE AGED;

EID: 0034082222     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. 1 Rheumatoid Arthritis Clinical Trial Archive Group. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. J Rheumatol 1995;22:218-23.
2. 2 Mckendry RJR, Dale P. Adverse effects of low-dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 1993;20:1850-6.
3. 3 Inokuma S, Sakata M, Ando J, Kobayashi S, Kiyosawa H, Nozawa F, et al. Immumoglobulin decrease accompanying adverse reaction with bucillamine. The Ryumachi 1993;33:316-24.
4. 4 Inokuma S, Sakata M, Yoshida A, Shiratori K, Kiyosawa H. Bucillamine induced pulmonary injury occurs with immunoglobulin decrease. J Rheumatol 1996;23:1282-5.
5. 5 Inokuma S, Ikoma T, Inoue S, Ueda A, Urano Y, Satou T, et al. Bucillamine induced lung injury in rheumatoid arthritis. The Ryumachi 1996;36:34-42.
6. 6 Barrera P, Boerbooms AMT, Janssen EM, Sauerwein RW, Gallati H, Mulder J, et al., Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor-α, and interleukin-6 levels in rheumatoid arthritis. Arthritis Rheum 1993;36: 1070-9.
7. 7 Crilly A, McInness IB, McDonald AG, Watson J, Capell HA, Madhok R. Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate. J Rheumatol 1995;22:224-6.
8. 8 Weinblatt ME, Trentham DE, Fraser PA, Holdsworth DE, Falchuk KR, Weissman BN, et al. Long-term prospective trial of low dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167-75.
9. 9 Wascher TC, Hermann J, Brezinschek HP, Brezinschek R, Wilders-Truschnig M, Rainer F, et al. Cell-type specific response of peripheral blood lymphocytes to methotrexate in the treatment of rheumatoid arthritis. Clin Invest 1994;72:535-40.
10. 10 Salaffi F, Manganeli P, Caroti M, Lammanna G, Cervini C. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature. Clin Rheumatol 1997;16:296-304.